Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Merck
Dow
Boehringer Ingelheim
Daiichi Sankyo
Queensland Health
AstraZeneca
Chubb

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019817

« Back to Dashboard

NDA 019817 describes IV PERSANTINE, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. Additional details are available on the IV PERSANTINE profile page.

The generic ingredient in IV PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 019817
Tradename:IV PERSANTINE
Applicant:Boehringer Ingelheim
Ingredient:dipyridamole
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019817

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 13, 1990TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Harvard Business School
Queensland Health
Chubb
Federal Trade Commission
Baxter
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.